12:00 AM
 | 
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Deals

Aptuit, Catalent Pharma deal

Catalent will acquire Aptuit's clinical trial supplies business for $410 million in cash on a cash...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >